Search
Search Results
##search.searchResults.foundPlural##
-
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2900PDF: 1584HTML: 233 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3545PDF: 1568HTML: 80 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1415PDF: 900Suppl. Files: 453HTML: 234 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2447HTML: 271PDF: 867 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2407PDF: 1589HTML: 626 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277649PDF: 1791HTML: 3864 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1743PDF: 1282HTML: 11492Figure1: 171Figure 2: 174 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1387PDF: 813HTML: 8660Fig 3 Savini: 170Fig 2 Savini: 176Fig 1 Savini Chest TC: 184Author letter to referees: 184 -
LENALIDOMIDE IN COMBINATION WITH DEXAMETHASONE IN ELDERLY PATIENTS WITH ADVANCED, RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL FAILURE
1273PDF: 889HTML: 1263fig 1A: 171figure1B: 145 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4239PDF: 1517HTML: 446 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1771PDF: 938HTML: 1110Untitled: 152Untitled: 170Untitled: 157Untitled: 158 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1026PDF: 625HTML: 77 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
873PDF: 685HTML: 318 -
DIAMOND BLACKFAN ANEMIA: A TERTIARY CARE CENTRE EXPERIENCE
1802PDF: 852HTML: 3594Diamond Blackfan Anemia: A Tertiary care centre experience: 255 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
2192PDF: 987HTML: 145Suppl. Files: 512 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4111PDF: 1937HTML: 1764 -
An unusual cause of anemia and encephalopathy
3897PDF: 856HTML: 1510 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2604PDF: 829HTML: 14949Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 305 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9049PDF: 6054HTML: 87953Fig.1b: 184Fig.1c: 188Fig.2a: 176Fig.2b: 175Fig.4: 188Fig.2c: 183Fig.3: 181Tab.1: 225Tab.2: 206Tab.3: 188Tab.4: 220Fig1a: 181 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1284PDF: 936HTML: 91 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
975PDF: 448HTML: 134 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7836PDF: 718HTML: 213 -
TOO MANY MOULDY JOINTS – MARIJUANA AND CHRONIC PULMONARY ASPERGILLOSIS
3126PDF: 1286HTML: 13989jdoe, Dening.MarijuanaFi7.doc: 195jdoe, Dening.MarijuanaFi6.doc: 181jdoe, Dening.MarijuanaFi5.doc: 176jdoe, Dening.MarijuanaFi4.doc: 187jdoe, Dening.MarijuanaFi3.doc: 196jdoe, Dening.MarijuanaFi2.doc: 239jdoe, Dening.MarijuanaFig1.doc: 210 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3231PDF: 1333HTML: 4129 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3767PDF: 1655HTML: 11586Figures Haase: 198 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1753PDF: 877HTML: 373Fig1: 231Fig.2: 251Fig. 3: 181Fig. 5: 195Fig. 4: 223







